Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of preoperative radiation therapy with capecitabine in rectal cancer (UMCC 0046)

Trial Profile

Phase II trial of preoperative radiation therapy with capecitabine in rectal cancer (UMCC 0046)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 Jan 2019

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Adenocarcinoma; Rectal cancer
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 09 Jan 2008 Status changed from in progress to discontinued.
    • 15 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top